Tesla building RNA microfactories to help fight Covid-19: Musk
Jul 3, 2020, 10:12 IST
San Francisco, July 3 (IANS) Tesla is helping German vaccine maker CureVac build portable molecular RNA printers to help produce quick doses of vaccine maker's Covid-19 candidate.
CureVac's printers are designed to quickly create mRNA vaccine candidates against known pathogens.
"Tesla, as a side project, is building RNA microfactories for CureVac & possibly others," Tesla CEO Elon Musk tweeted on Thursday.
Pharmaceutical companies like CureVac are working to create a Covid-19 vaccine using "messenger RNA," which can be manually inserted into cells to initiate an immune response.
CureVac says its mRNA vaccine candidates direct cells to make proteins or antigens against various diseases.
CureVac's vaccine candidate called 'CVnCoV' received German and Belgian regulatory clearance to enter phase 1 human testing last month.
Other companies making RNA vaccines include Moderna and Pfizer and BioNTech.
According to Forbes, Moderna is looking to start phase 3 trials by July for its vaccine candidate named mRNA-1273.
BioNTech is developing the vaccine inside of China with Fosun Pharma, a Chinese pharmaceutical company, and Pfizer said they will develop the company's experimental Covid-19 vaccine outside of China.
na/
Advertisement
CureVac's printers are designed to quickly create mRNA vaccine candidates against known pathogens.
"Tesla, as a side project, is building RNA microfactories for CureVac & possibly others," Tesla CEO Elon Musk tweeted on Thursday.
Complimentary Tech Event
Transform talent with learning that works
Capability development is critical for businesses who want to push the envelope of innovation.Discover how business leaders are strategizing around building talent capabilities and empowering employee transformation.Know More
Pharmaceutical companies like CureVac are working to create a Covid-19 vaccine using "messenger RNA," which can be manually inserted into cells to initiate an immune response.
Advertisement
CureVac's vaccine candidate called 'CVnCoV' received German and Belgian regulatory clearance to enter phase 1 human testing last month.
Other companies making RNA vaccines include Moderna and Pfizer and BioNTech.
According to Forbes, Moderna is looking to start phase 3 trials by July for its vaccine candidate named mRNA-1273.
BioNTech is developing the vaccine inside of China with Fosun Pharma, a Chinese pharmaceutical company, and Pfizer said they will develop the company's experimental Covid-19 vaccine outside of China.
Advertisement
--IANSna/
(This story has not been edited by www.businessinsider.in and is auto–generated from a syndicated feed we subscribe to.)